Celldex Therapeutics sell Wells Fargo & Company
Start price
22.08.23
/
50%
€26.60
Target price
22.08.24
-
Performance (%)
18.80%
End price
23.08.24
€31.60
Summary
This prediction ended on 23.08.24 with a price of €31.60. The SELL prediction by Wells_Fargo___Compan finished with a performance of 18.80%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | 10.714% | 10.714% | 45.313% |
| iShares Core DAX® | -0.372% | 5.236% | 16.908% |
| iShares Nasdaq 100 | -1.950% | 1.680% | 19.890% |
| iShares Nikkei 225® | -1.690% | 7.286% | 12.202% |
| iShares S&P 500 | -0.399% | 2.379% | 20.975% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Wells Fargo & Company. They set an "underweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten